This company put everything into one drug. Now it's cutting half of staff. Here's more on how Theravance Biopharma will close its research unit, cut staff below 50 and explore a sale after a ...
The company is investing $1.6 billion in capital expenditures this fiscal year. Much of that is going toward store growth and megahub expansion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results